succinobucol has been researched along with tolvaptan in 1 studies
| Studies (succinobucol) | Trials (succinobucol) | Recent Studies (post-2010) (succinobucol) | Studies (tolvaptan) | Trials (tolvaptan) | Recent Studies (post-2010) (tolvaptan) |
|---|---|---|---|---|---|
| 53 | 5 | 16 | 967 | 172 | 786 |
| Protein | Taxonomy | succinobucol (IC50) | tolvaptan (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 9.99 | |
| Vasopressin V2 receptor | Homo sapiens (human) | 0.1486 | |
| Vasopressin V1a receptor | Homo sapiens (human) | 0.351 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horowitz, J; Kaski, JC; McMurray, JJ; Recio-Mayoral, A; Remme, WJ; van Veldhuisen, DJ | 1 |
1 other study(ies) available for succinobucol and tolvaptan
| Article | Year |
|---|---|
Clinical trials update from the European Society of Cardiology Congress in Vienna, 2007: PROSPECT, EVEREST, ARISE, ALOFT, FINESSE, Prague-8, CARESS in MI and ACUITY.
Topics: Abciximab; Acute Coronary Syndrome; Amides; Antibodies, Monoclonal; Benzazepines; Clinical Trials as Topic; Clopidogrel; Electrocardiography; Europe; Fumarates; Heart Diseases; Heart Failure; Hirudins; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptide Fragments; Probucol; Recombinant Proteins; Ticlopidine; Tolvaptan | 2007 |